nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—MPO—superior mesenteric artery—bile duct cancer	0.287	0.335	CbGeAlD
Oxaliplatin—ABCC2—bile duct—bile duct cancer	0.0822	0.0959	CbGeAlD
Oxaliplatin—ABCC2—bile—bile duct cancer	0.0631	0.0737	CbGeAlD
Oxaliplatin—MT2A—gall bladder—bile duct cancer	0.0484	0.0565	CbGeAlD
Oxaliplatin—MT1A—pancreas—bile duct cancer	0.0268	0.0312	CbGeAlD
Oxaliplatin—NQO1—gall bladder—bile duct cancer	0.0244	0.0285	CbGeAlD
Oxaliplatin—GSTP1—gall bladder—bile duct cancer	0.0218	0.0255	CbGeAlD
Oxaliplatin—MT1A—liver—bile duct cancer	0.017	0.0199	CbGeAlD
Oxaliplatin—SOD1—pancreas—bile duct cancer	0.0169	0.0197	CbGeAlD
Oxaliplatin—ATP7B—liver—bile duct cancer	0.0153	0.0178	CbGeAlD
Oxaliplatin—MT2A—liver—bile duct cancer	0.0142	0.0166	CbGeAlD
Oxaliplatin—GSTT1—liver—bile duct cancer	0.0139	0.0162	CbGeAlD
Oxaliplatin—MT1A—lymph node—bile duct cancer	0.0131	0.0152	CbGeAlD
Oxaliplatin—ATP7A—liver—bile duct cancer	0.0123	0.0143	CbGeAlD
Oxaliplatin—GSTM1—Glutathione metabolism—IDH1—bile duct cancer	0.0122	0.0854	CbGpPWpGaD
Oxaliplatin—ATP7B—lymph node—bile duct cancer	0.0117	0.0137	CbGeAlD
Oxaliplatin—NQO1—pancreas—bile duct cancer	0.0113	0.0131	CbGeAlD
Oxaliplatin—SOD1—liver—bile duct cancer	0.0108	0.0125	CbGeAlD
Oxaliplatin—SLC31A1—liver—bile duct cancer	0.0105	0.0122	CbGeAlD
Oxaliplatin—MPO—pancreas—bile duct cancer	0.0104	0.0121	CbGeAlD
Oxaliplatin—GSTM1—liver—bile duct cancer	0.0102	0.0119	CbGeAlD
Oxaliplatin—GSTP1—pancreas—bile duct cancer	0.0101	0.0117	CbGeAlD
Oxaliplatin—ATP7A—lymph node—bile duct cancer	0.00942	0.011	CbGeAlD
Oxaliplatin—SOD1—lymph node—bile duct cancer	0.00824	0.00962	CbGeAlD
Oxaliplatin—SLC31A1—lymph node—bile duct cancer	0.00803	0.00937	CbGeAlD
Oxaliplatin—GSTM1—lymph node—bile duct cancer	0.00784	0.00915	CbGeAlD
Oxaliplatin—NQO1—liver—bile duct cancer	0.00717	0.00836	CbGeAlD
Oxaliplatin—MPO—liver—bile duct cancer	0.00659	0.00769	CbGeAlD
Oxaliplatin—GSTP1—liver—bile duct cancer	0.0064	0.00747	CbGeAlD
Oxaliplatin—SLC22A1—liver—bile duct cancer	0.00573	0.00669	CbGeAlD
Oxaliplatin—NQO1—lymph node—bile duct cancer	0.00549	0.00641	CbGeAlD
Oxaliplatin—SLC22A3—liver—bile duct cancer	0.00548	0.00639	CbGeAlD
Oxaliplatin—ABCC2—liver—bile duct cancer	0.00514	0.006	CbGeAlD
Oxaliplatin—MPO—lymph node—bile duct cancer	0.00505	0.0059	CbGeAlD
Oxaliplatin—CYP1B1—liver—bile duct cancer	0.00503	0.00587	CbGeAlD
Oxaliplatin—GSTP1—lymph node—bile duct cancer	0.00491	0.00573	CbGeAlD
Oxaliplatin—SLC22A3—lymph node—bile duct cancer	0.0042	0.0049	CbGeAlD
Oxaliplatin—ABCC2—lymph node—bile duct cancer	0.00394	0.0046	CbGeAlD
Oxaliplatin—CYP1B1—lymph node—bile duct cancer	0.00386	0.0045	CbGeAlD
Oxaliplatin—ABCG2—liver—bile duct cancer	0.00375	0.00437	CbGeAlD
Oxaliplatin—CA4—lymph node—bile duct cancer	0.00374	0.00437	CbGeAlD
Oxaliplatin—CYP1A2—liver—bile duct cancer	0.00361	0.00421	CbGeAlD
Oxaliplatin—CYP1A1—liver—bile duct cancer	0.00356	0.00415	CbGeAlD
Oxaliplatin—CYP2E1—liver—bile duct cancer	0.00324	0.00379	CbGeAlD
Oxaliplatin—ABCG2—lymph node—bile duct cancer	0.00287	0.00335	CbGeAlD
Oxaliplatin—CYP1A1—lymph node—bile duct cancer	0.00273	0.00318	CbGeAlD
Oxaliplatin—MPO—IL23-mediated signaling events—NOS2—bile duct cancer	0.00266	0.0186	CbGpPWpGaD
Oxaliplatin—SOD1—Validated nuclear estrogen receptor alpha network—SMAD4—bile duct cancer	0.00264	0.0185	CbGpPWpGaD
Oxaliplatin—MT1A—Copper homeostasis—TP53—bile duct cancer	0.00262	0.0183	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet degranulation—HGF—bile duct cancer	0.00214	0.015	CbGpPWpGaD
Oxaliplatin—SOD1—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.00204	0.0143	CbGpPWpGaD
Oxaliplatin—ATP7B—Copper homeostasis—TP53—bile duct cancer	0.00198	0.0139	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—NOS2—bile duct cancer	0.00192	0.0134	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—MMP9—bile duct cancer	0.00184	0.0129	CbGpPWpGaD
Oxaliplatin—GSTM1—NRF2 pathway—SLC5A5—bile duct cancer	0.00184	0.0128	CbGpPWpGaD
Oxaliplatin—SLC31A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.0018	0.0126	CbGpPWpGaD
Oxaliplatin—ATP7A—Copper homeostasis—TP53—bile duct cancer	0.00169	0.0118	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—MMP2—bile duct cancer	0.00165	0.0115	CbGpPWpGaD
Oxaliplatin—SLC31A1—Copper homeostasis—TP53—bile duct cancer	0.00162	0.0113	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.0016	0.0112	CbGpPWpGaD
Oxaliplatin—MT2A—Copper homeostasis—TP53—bile duct cancer	0.00159	0.0111	CbGpPWpGaD
Oxaliplatin—GSTP1—NRF2 pathway—SLC5A5—bile duct cancer	0.00156	0.0109	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—FAR2—bile duct cancer	0.00154	0.0108	CbGpPWpGaD
Oxaliplatin—NQO1—NRF2 pathway—SLC5A5—bile duct cancer	0.00152	0.0106	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—TGFB1—bile duct cancer	0.00152	0.0106	CbGpPWpGaD
Oxaliplatin—GSTM1—NRF2 pathway—TGFBR2—bile duct cancer	0.00148	0.0103	CbGpPWpGaD
Oxaliplatin—GSTM1—NRF2 pathway—HGF—bile duct cancer	0.00136	0.0095	CbGpPWpGaD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—bile duct cancer	0.00131	0.00912	CbGpPWpGaD
Oxaliplatin—GSTP1—NRF2 pathway—TGFBR2—bile duct cancer	0.00126	0.00879	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—TP53—bile duct cancer	0.00125	0.00874	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00125	0.0087	CbGpPWpGaD
Oxaliplatin—NQO1—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00124	0.00869	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—MMP9—bile duct cancer	0.00124	0.00864	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HGF—bile duct cancer	0.00123	0.00859	CbGpPWpGaD
Oxaliplatin—NQO1—NRF2 pathway—TGFBR2—bile duct cancer	0.00123	0.00857	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—PTGS2—bile duct cancer	0.00119	0.00834	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00116	0.00809	CbGpPWpGaD
Oxaliplatin—GSTP1—NRF2 pathway—HGF—bile duct cancer	0.00116	0.00808	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—IL6—bile duct cancer	0.00114	0.008	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00113	0.00793	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00113	0.00793	CbGpPWpGaD
Oxaliplatin—NQO1—NRF2 pathway—HGF—bile duct cancer	0.00113	0.00787	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.00112	0.00783	CbGpPWpGaD
Oxaliplatin—ATP7B—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00112	0.00783	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00107	0.00749	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL6—bile duct cancer	0.00106	0.00744	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—TP53—bile duct cancer	0.00102	0.0071	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—PTGS2—bile duct cancer	0.00101	0.00709	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—EGFR—bile duct cancer	0.000999	0.00698	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—FAR2—bile duct cancer	0.000995	0.00695	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000977	0.00683	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.000957	0.00669	CbGpPWpGaD
Oxaliplatin—ATP7A—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000952	0.00666	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.000951	0.00665	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000944	0.0066	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—NRAS—bile duct cancer	0.000928	0.00649	CbGpPWpGaD
Oxaliplatin—SLC31A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000913	0.00638	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000911	0.00637	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000889	0.00621	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—FAR2—bile duct cancer	0.000882	0.00616	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet degranulation—TGFB1—bile duct cancer	0.000874	0.00611	CbGpPWpGaD
Oxaliplatin—ATP7B—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00087	0.00608	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—FAR2—bile duct cancer	0.000846	0.00591	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TP53—bile duct cancer	0.000839	0.00586	CbGpPWpGaD
Oxaliplatin—SOD1—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.000833	0.00582	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—FAR2—bile duct cancer	0.000824	0.00576	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000824	0.00576	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—KRAS—bile duct cancer	0.000799	0.00558	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—NRAS—bile duct cancer	0.000789	0.00552	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.000769	0.00537	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—IL6—bile duct cancer	0.000768	0.00537	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—SLC5A5—bile duct cancer	0.000765	0.00535	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—IDH2—bile duct cancer	0.000754	0.00527	CbGpPWpGaD
Oxaliplatin—ATP7A—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00074	0.00517	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TP53—bile duct cancer	0.000732	0.00512	CbGpPWpGaD
Oxaliplatin—CYP1B1—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000719	0.00503	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.000713	0.00498	CbGpPWpGaD
Oxaliplatin—SLC31A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000709	0.00496	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—KRAS—bile duct cancer	0.000679	0.00475	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—HRAS—bile duct cancer	0.000679	0.00475	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—IL6—bile duct cancer	0.00067	0.00468	CbGpPWpGaD
Oxaliplatin—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000662	0.00462	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—IDH1—bile duct cancer	0.000648	0.00453	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—TGFBR2—bile duct cancer	0.000616	0.00431	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—IL6—bile duct cancer	0.00061	0.00426	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000598	0.00418	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—HRAS—bile duct cancer	0.000577	0.00404	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—FAR2—bile duct cancer	0.000568	0.00397	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—HGF—bile duct cancer	0.000566	0.00396	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.000556	0.00388	CbGpPWpGaD
Oxaliplatin—GSTM1—NRF2 pathway—TGFB1—bile duct cancer	0.000554	0.00387	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000547	0.00383	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.000545	0.00381	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000545	0.00381	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000543	0.0038	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—NRAS—bile duct cancer	0.000539	0.00377	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—IL6—bile duct cancer	0.000532	0.00372	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000515	0.0036	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—GNAS—bile duct cancer	0.000515	0.0036	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—HGF—bile duct cancer	0.00049	0.00343	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—IDH2—bile duct cancer	0.000486	0.00339	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.000473	0.00331	CbGpPWpGaD
Oxaliplatin—GSTP1—NRF2 pathway—TGFB1—bile duct cancer	0.000471	0.00329	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—KRAS—bile duct cancer	0.000464	0.00324	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—TP53—bile duct cancer	0.00046	0.00321	CbGpPWpGaD
Oxaliplatin—NQO1—NRF2 pathway—TGFB1—bile duct cancer	0.000459	0.00321	CbGpPWpGaD
Oxaliplatin—CYP1A1—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000443	0.0031	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000438	0.00306	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—IDH2—bile duct cancer	0.000431	0.00301	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—SLC5A5—bile duct cancer	0.000428	0.00299	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—IL6—bile duct cancer	0.000421	0.00294	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—IDH1—bile duct cancer	0.000418	0.00292	CbGpPWpGaD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000415	0.0029	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—IDH2—bile duct cancer	0.000413	0.00289	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—IDH2—bile duct cancer	0.000402	0.00281	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HGF—bile duct cancer	0.000401	0.00281	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—FAR2—bile duct cancer	0.000396	0.00277	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HRAS—bile duct cancer	0.000394	0.00276	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000388	0.00271	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000387	0.0027	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IL6—bile duct cancer	0.000377	0.00264	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—NOS2—bile duct cancer	0.000376	0.00263	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000373	0.00261	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—IDH1—bile duct cancer	0.00037	0.00259	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000368	0.00257	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—FAR2—bile duct cancer	0.00036	0.00252	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—FAR2—bile duct cancer	0.000356	0.00249	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—IDH1—bile duct cancer	0.000355	0.00248	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000349	0.00244	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—IDH1—bile duct cancer	0.000346	0.00242	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.000342	0.00239	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000336	0.00235	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.000336	0.00235	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000336	0.00235	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—FAR2—bile duct cancer	0.000332	0.00232	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—GNAS—bile duct cancer	0.000332	0.00232	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000317	0.00222	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.000302	0.00211	CbGpPWpGaD
Oxaliplatin—CYP1A2—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000282	0.00197	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—IDH2—bile duct cancer	0.000278	0.00194	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—TP53—bile duct cancer	0.000277	0.00193	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—SLC5A5—bile duct cancer	0.000276	0.00193	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00027	0.00188	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000261	0.00183	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—FAR2—bile duct cancer	0.000259	0.00181	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—IL6—bile duct cancer	0.000253	0.00177	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000245	0.00171	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—SLC5A5—bile duct cancer	0.000244	0.00171	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—FAR2—bile duct cancer	0.000244	0.0017	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—TP53—bile duct cancer	0.000242	0.00169	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—IDH1—bile duct cancer	0.000239	0.00167	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000235	0.00164	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—SLC5A5—bile duct cancer	0.000234	0.00164	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—ERBB2—bile duct cancer	0.000231	0.00162	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—TGFB1—bile duct cancer	0.000231	0.00161	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00023	0.00161	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—SLC5A5—bile duct cancer	0.000228	0.0016	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—IL6—bile duct cancer	0.000221	0.00155	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.000218	0.00153	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—NRAS—bile duct cancer	0.000215	0.0015	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—GNAS—bile duct cancer	0.000214	0.0015	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000214	0.0015	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.000214	0.0015	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000213	0.00149	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000211	0.00147	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000202	0.00141	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TGFB1—bile duct cancer	0.0002	0.0014	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000197	0.00137	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—IDH2—bile duct cancer	0.000193	0.00135	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00019	0.00133	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—GNAS—bile duct cancer	0.00019	0.00133	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—KRAS—bile duct cancer	0.000185	0.00129	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—GNAS—bile duct cancer	0.000182	0.00127	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—PTGS2—bile duct cancer	0.000178	0.00125	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—GNAS—bile duct cancer	0.000177	0.00124	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—NRAS—bile duct cancer	0.000176	0.00123	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—IDH2—bile duct cancer	0.000176	0.00123	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—IDH2—bile duct cancer	0.000174	0.00122	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000172	0.0012	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—IDH1—bile duct cancer	0.000166	0.00116	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000166	0.00116	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TP53—bile duct cancer	0.000164	0.00115	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000164	0.00115	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—IDH2—bile duct cancer	0.000162	0.00113	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—EGFR—bile duct cancer	0.00016	0.00112	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—SLC5A5—bile duct cancer	0.000157	0.0011	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—HRAS—bile duct cancer	0.000157	0.0011	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—FAR2—bile duct cancer	0.000155	0.00109	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000153	0.00107	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—KRAS—bile duct cancer	0.000152	0.00106	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—IDH1—bile duct cancer	0.000151	0.00106	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—IDH1—bile duct cancer	0.00015	0.00105	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000147	0.00102	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—IDH1—bile duct cancer	0.00014	0.000975	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HRAS—bile duct cancer	0.000129	0.0009	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—IDH2—bile duct cancer	0.000126	0.000883	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IL6—bile duct cancer	0.000123	0.000862	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—GNAS—bile duct cancer	0.000122	0.000855	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000122	0.00085	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—IDH2—bile duct cancer	0.000119	0.000832	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PTGS2—bile duct cancer	0.000115	0.000804	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000113	0.000792	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—SLC5A5—bile duct cancer	0.00011	0.000767	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—IDH1—bile duct cancer	0.000109	0.000759	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000103	0.000718	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—IDH1—bile duct cancer	0.000102	0.000716	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PTGS2—bile duct cancer	0.000102	0.000713	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—SLC5A5—bile duct cancer	9.98e-05	0.000697	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—SLC5A5—bile duct cancer	9.88e-05	0.00069	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PTGS2—bile duct cancer	9.78e-05	0.000683	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PTGS2—bile duct cancer	9.53e-05	0.000666	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—HRAS—bile duct cancer	9.32e-05	0.000651	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—SLC5A5—bile duct cancer	9.21e-05	0.000643	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—HRAS—bile duct cancer	8.68e-05	0.000607	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—GNAS—bile duct cancer	8.52e-05	0.000596	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—GNAS—bile duct cancer	7.75e-05	0.000542	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—GNAS—bile duct cancer	7.67e-05	0.000536	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—IDH2—bile duct cancer	7.59e-05	0.000531	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—SLC5A5—bile duct cancer	7.17e-05	0.000501	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—GNAS—bile duct cancer	7.15e-05	0.0005	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—SLC5A5—bile duct cancer	6.76e-05	0.000472	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PTGS2—bile duct cancer	6.57e-05	0.000459	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—IDH1—bile duct cancer	6.53e-05	0.000456	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	6.33e-05	0.000442	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—GNAS—bile duct cancer	5.57e-05	0.000389	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—GNAS—bile duct cancer	5.25e-05	0.000367	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PTGS2—bile duct cancer	4.58e-05	0.00032	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—SLC5A5—bile duct cancer	4.31e-05	0.000301	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PTGS2—bile duct cancer	4.16e-05	0.000291	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PTGS2—bile duct cancer	4.12e-05	0.000288	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.04e-05	0.000282	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PTGS2—bile duct cancer	3.84e-05	0.000268	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—GNAS—bile duct cancer	3.35e-05	0.000234	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PTGS2—bile duct cancer	2.99e-05	0.000209	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PTGS2—bile duct cancer	2.82e-05	0.000197	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PTGS2—bile duct cancer	1.8e-05	0.000126	CbGpPWpGaD
